Merck KGaA Sticks With Structure, Eyes Smaller Healthcare Deals
Executive Summary
There may be a trend towards spinning off business units but Merck continues to sees its three-pillar structure as providing the best protection from downturns in any individual segment.
You may also be interested in...
Deal Watch: Graphite Exits Via Reverse Merger With Presbyopia Specialist LENZ
Plus deals involving Abliva/Owl, Selecta/Cartesian, Novo Nordisk/Genevant, AbbVie/Aldeyra and more.
Bayer To Split Off Consumer Or Crop Science, Or Both, Or Neither
After a miserable third quarter the German group is cutting jobs and considering splitting up, but concrete decisions are thin on the ground.
Sanofi Stock Slides On Lower Profit Forecast And Consumer Health Spinoff Plan
The French drugmaker is significantly upping its R&D spend and exiting consumer care, a strategy CEO Paul Hudson has stoutly defended following a slump in the share price.